Linden Thomas Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Linden Thomas Advisory Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.24M	Buy	8,112 +9	+0.1%	+$4.61K	0.34%	69
2026 Q2	$4.03M	Sell	8,103 -20	-0.2%	-$8.86K	0.32%	73
2026 Q1	$3.63M	Sell	8,123 -282	-3%	-$131K	0.35%	72
2025 Q4	$3.81M	Sell	8,405 -14	-0.2%	-$6.03K	0.39%	62
2025 Q3	$3.3M	Buy	8,419 +258	+3%	+$108K	0.33%	76
2025 Q2	$3.63M	Buy	8,161 +428	+6%	+$197K	0.4%	66
2025 Q1	$3.75M	Buy	7,733 +292	+4%	+$136K	0.49%	41
2024 Q4	$3M	Buy	7,441 +644	+9%	+$299K	0.38%	63
2024 Q3	$3.16M	Buy	6,797 +613	+10%	+$294K	0.43%	45
2024 Q2	$2.9M	Sell	6,184 -139	-2%	-$60.3K	0.45%	43
2024 Q1	$2.64M	Buy	6,323 +323	+5%	+$137K	0.42%	42
2023 Q4	$2.44M	Buy	6,000 +541	+10%	+$200K	0.46%	42
2023 Q3	$1.9M	Sell	5,459 -7,135	-57%	-$2.5M	0.42%	49
2023 Q2	$4.43M	Buy	12,594 +626	+5%	+$211K	0.98%	6
2023 Q1	$3.77M	Buy	11,968 +482	+4%	+$145K	0.94%	11
2022 Q4	$3.32M	Buy	+11,486	New	+$3.5M	0.93%	7

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Linden Thomas Advisory Services's VRTX Position: Q3 2026 in Review

Linden Thomas Advisory Services increased its Vertex Pharmaceuticals (VRTX) stake by 0.11% in Q3 2026, buying an estimated $4.61K and bringing the position to 8,112 shares worth $4.24M. The position accounts for 0.34% of the portfolio, ranked #69.

Linden Thomas Advisory Services first reported a position in VRTX in Q4 2022 and has held it in 16 quarters since. The position peaked at $4.43M in Q2 2023. 658 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Linden Thomas Advisory Services held 8,112 shares of Vertex Pharmaceuticals worth $4.24M as of Q3 2026.
Linden Thomas Advisory Services bought 9 Vertex Pharmaceuticals shares in Q3 2026, an estimated $4.61K.
Vertex Pharmaceuticals made up 0.34% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #69 holding.
Linden Thomas Advisory Services first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
Linden Thomas Advisory Services's Vertex Pharmaceuticals position peaked at $4.43M in Q2 2023.
658 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.